Human Health and Potential (HHP)

Researchers engineer specialized T cells that can transiently and effectively attack liver cancer cells even in the presence of immunosuppressive drugs.

Maternal antibodies can cross the placenta and pass on mother’s allergies to her children in the womb.

A new computational method called xPore identifies and estimates the number of specific RNA modifications in biological samples.

Using whole-exome sequencing, scientists have identified a gene likely linked to a common eye disorder that can lead to blindness in the elderly.

Using single-cell sequencing technology, A*STAR scientists have identified a rare population of liver cells susceptible to damage from SARS-CoV-2 infections.

A*STAR’s steady investments in R&D and talent create the ideal conditions for impactful science, says its Chief Executive Officer Frederick Chew.

Unique immune responses shield some COVID-19 patients from the disease’s worst effects.

A new, cost-effective barrier enclosure protects healthcare workers by effectively containing airborne viral particles from COVID-19 patients.

Contrary to popular belief, a new A*STAR study shows that HIV mutations are far from random, emerging at specific locations at specific rates.

Broad-acting antibiotics can disrupt the gut microbiome and create the perfect conditions for potentially life-threatening yeast infections to flourish.

Elevated levels of inflammatory factors may be linked to persistent COVID-19 symptoms, researchers find.

A protein in cilia called CFAP53 is responsible for the distinct beat patterns during embryonic development, researchers say.